WUHAN CALMLAND PHARMACEUTICALS CO LTD

Overview

WUHAN CALMLAND PHARMACEUTICALS CO LTD is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering AZILSARTAN; AZILSARTAN MEDOXOMIL POTASSIUM; DECITABINE; DOCETAXEL; EPINASTINE HYDROCHLORIDE; NICOTINE.

API / Drug Master Files

WUHAN CALMLAND PHARMACEUTICALS CO LTD holds 10 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• NICOTINEActive2025-06-26
• AZILSARTANActive2024-10-20
• EPINASTINE HYDROCHLORIDEActive2024-08-07
• AZILSARTAN MEDOXOMIL POTASSIUMActive2024-07-12
• TENOFOVIR ALAFENMIDE FUMARATEActive2024-06-21
• DOCETAXELActive2022-03-09
• PACLITAXELActive2018-01-25
• DECITABINEActive2017-12-08
• PEMETREXED DISODIUM HEMIPENTAHYDRATEActive2017-07-27
• PEMETREXED DISODIUM HEPTAHYDRATEActive2017-03-31

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to WUHAN CALMLAND PHARMACEUTICALS CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.